Thrombogenic activity of leukocytes.
D000818:Animals; D001011:Aorta; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D004731:Endotoxins / Q000008:administration & dosage / Q000494:pharmacology*; D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use; D007238:Infarction / Q000209:etiology; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007673:Kidney Cortex Necrosis / Q000209:etiology / Q000473:pathology; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D009203:Myocardial Infarction / Q000209:etiology; D010537:Peritoneum; D011517:Prothrombin Time; D011655:Pulmonary Embolism / Q000209:etiology / Q000473:pathology; D011817:Rabbits; D012790:Shwartzman Phenomenon; D013925:Thromboplastin / Q000494:pharmacology; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control
D001779:Blood Coagulation Factors; D004731:Endotoxins; D006493:Heparin; D013925:Thromboplastin